NeoGenomics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. NeoGenomics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 16% to $591,643,000. The net income raised on -$87,968,000 and profit margin reached -15%. Total operating expenses were $341,252,000.

Profit Margin

NeoGenomics, Inc. (NASDAQ:NEO): Profit margin
2014 87.06M 1.13M 1.3%
2015 99.80M -2.53M -2.54%
2016 244.08M -5.72M -2.34%
2017 258.61M -846K -0.33%
2018 276.74M 2.64M 0.95%
2019 408.83M 8.00M 1.96%
2020 444.44M 4.17M 0.94%
2021 484.32M -8.34M -1.72%
2022 509.72M -144.25M -28.3%
2023 591.64M -87.96M -14.87%

NEO Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
591.64M509.72M484.32M444.44M408.83M276.74M258.61M244.08M99.80M87.06M
Cost of revenue
347.03M321.83M297.26M258.55M211.99M149.47M138.29M133.70M56.04M46.35M
Gross profit
244.60M187.89M187.06M185.89M196.83M127.26M120.31M110.37M43.75M40.71M
Operating exp.
Research and development
27.30M30.32M21.87M8.22M8.48M3.00M3.63M4.64M4.19M2.68M
Selling and marketing
70.84M67.32M62.59M47.86M47.35M29.40M24.54M23.91M11.56M11.99M
Total operating expenses
341.25M341.00M305.81M199.88M183.83M117.22M116.93M104.34M49.39M38.49M
Operating income
-107.73M-153.10M-9.99M-2.13M8.37M10.04M3.38M2.57M-5.63M2.21M
Other income (expenses), net
10.63M-6.23M-5.08M-64K-4.73M14K-5.55M-3.46M1.14M-929K
Income before tax
-97.09M-159.34M-15.07M-14.05M3.64M3.82M-3.48M-7.42M-4.48M1.28M
Income tax expense
-9.12M-15.09M-6.72M-18.22M-4.36M1.18M-2.63M-1.70M-1.95M157K
Net income
-87.96M-144.25M-8.34M4.17M8.00M2.64M-846K-5.72M-2.53M1.13M
Earnings per share
Basic EPS
-0.7-1.16-0.060.030.070.02-0.01-0.07-0.040.02
Diluted EPS
-0.7-1.16-0.060.030.070.02-0.01-0.07-0.040.02
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source